Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 158 CHF -5.5%
Market Cap: CHf3.2B

Medacta Group SA
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medacta Group SA
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Medacta Group SA
SIX:MOVE
Research & Development
-€21.4m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Research & Development
-CHf27.3m
CAGR 3-Years
24%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Sonova Holding AG
SIX:SOON
Research & Development
-CHf232.3m
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
Straumann Holding AG
SIX:STMN
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medmix Ltd
SIX:MEDX
Research & Development
-CHf25.4m
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Medacta Group SA
Glance View

Market Cap
3.2B CHF
Industry
Health Care

Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.

MOVE Intrinsic Value
HIDDEN
Show

See Also

What is Medacta Group SA's Research & Development?
Research & Development
-21.4m EUR

Based on the financial report for Jun 30, 2025, Medacta Group SA's Research & Development amounts to -21.4m EUR.

What is Medacta Group SA's Research & Development growth rate?
Research & Development CAGR 5Y
-23%

Over the last year, the Research & Development growth was -6%. The average annual Research & Development growth rates for Medacta Group SA have been -14% over the past three years , -23% over the past five years .

Back to Top